Cardinal Health’s CAH Monoject syringes get unfavorable FDA recommendation following reports of delay in therapy as well as inaccurate therapy (overdose or underdose) when used with a syringe pump or ...
The FDA has doled out its most serious classification to a recall of some Cardinal Health medical supplies. In this case, the recall doesn’t describe a product removal, but merely a correction to the ...
The FDA has alerted healthcare providers not to use Cardinal Health (NYSE:CAH) Monoject syringes with syringe pumps and patient-controlled analgesia, or PCA, pumps until it further evaluates reports ...
FILE PHOTO: Signage is seen outside of FDA headquarters in White Oak, Maryland (Reuters) -The U.S. Food and Drug Administration on Monday warned healthcare providers and facilities not to use Cardinal ...
The Food and Drug Administration has posted a Class I notice about Becton Dickinson infusion pumps affected by compatibility issues with Cardinal Health Monoject syringes. Cardinal sent an urgent ...
Just a week after issuing a notice giving its most serious rating to Cardinal Health’s recall of certain syringes, the FDA has put out a letter to healthcare providers warning that the recall may not ...
Only days after MD+DI reported Cardinal Health was embroiled in a Class I recall of its Cardinal branded Monoject syringes, FDA has moved to clarify its advice for clinicians specific to the recall.
The U.S. FDA advises health care providers (HCPs) to avoid using Monoject syringes distributed by Cardinal Health with syringe pumps or patient-controlled analgesia (PCA) pumps because of ...
Dec 1 (Reuters) - The U.S. Food and Drug Administration (FDA) said on Friday that Becton Dickinson BDX.N is recalling its Alaris infusion pumps due to compatibility issues with Cardinal Health's CAH.N ...
Covidien announced a voluntary recall of certain lots of Monoject prefill flush syringes. This recall is following the risk that a number of the syringes were filled with water but not subjected to ...
Dec 1 (Reuters) - The U.S. Food and Drug Administration (FDA) said on Friday that Becton Dickinson (BDX.N), opens new tab is recalling its Alaris infusion pumps due to compatibility issues with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results